All In MedTech

FDA Clearance Tracker · P250033-S004

NEXUS Aortic Arch Stent Graft System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 21, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 21, 2026

Approved

Time to decision

90 days

Received Jun 23, 2026. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P250033-S004
Device name
NEXUS Aortic Arch Stent Graft System
Applicant location
Alta, WY
Received
Jun 23, 2026
Decided
Sep 21, 2026
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P250033

Device type

Device class
Class III

Every decision under product code SDZ

FDA's approval statement

As written in FDA's record.

approval for a 3 year shelf-life for the NEXUS Aortic Arch Stent Graft System

Source documents

Other decisions for Endospan , Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.